2019 Speakers


Stewart Abbot, Chief Scientific Officer, Adicet Bio

Karen S Aboody, Professor, City of Hope Comprehensive Cancer Center

Blake Aftab, Vice President and Head of Preclinical Science & Translational Medicine, Atara Biotherapeutics

Nabil Al Humadi, Pharmacologist And Toxicologist, Food and Drug Administration (FDA)

Dr M Javad Aman, Chief Executive Officer, Integrated Biotherapeutics

Bruno Anspach, Director Of Clinical Operations Latin America - Vaccines, GlaxoSmithKline

Ramesh Baliga, Vice President Of Discovery Biology, IgM. Biosciences Inc

Seth Bannon, Founding Partner, Fifty Years

Sarah Bartsch, Project Director, PHICOR, Sr. RFCUNY Research Associate, City University of New York

Reid Behrendt, Digital Marketing Director, Emergent Biosolutions

Sylvain Berlemont, Chief Executive Officer And Founder, Keen Eye Technologies

Praveen Bommareddy, Associate Director, Translational Research,, Replimune

Catharine Mans Bosio, Senior Investigator, NIAID-NIH

Maureen Bruhns, Senior Director, Analytical Development, Sutro Biopharma

David Canton, Director, R&D And Clinical Science, OncoSec Medical

Zhifeng Chen, Principal Scientist, Merck

Grace Chen, Deputy Chief Of The Clinical Trials Program In The Vrc, National Institutes of Health

Tony Chen, President and Chief Executive Officer, PrimeVax Immuno Oncology Inc

Tony Chen | President and Chief Executive Officer | PrimeVax Immuno Oncology Inc » speaking at Vaccine West Coast

Cariad Chester, Principal, Aquilo

Cariad Chester | Principal | Aquilo » speaking at Vaccine West Coast

Nicholas Choong, Executive Director, Clinical Development, Seattle Genetics Inc

Dr Chris Clegg, President, Founder And Chief Scientific Officer, TRIA Bioscience

Dr Chris Clegg | President, Founder And Chief Scientific Officer | TRIA Bioscience » speaking at Vaccine West Coast

Dr Rachel Clemens, Commercial Innovation Manager, Center for the Advancement of Science In Space

Jennifer Cochran, Chief Scientist, Lagunita Biosciences

Dr Ezra Cohen, Associate Director Of Moores Cancer Center, U.C. San Diego Moores Cancer Center

Jason E Comer, Assistant Professor, Department Microbiology And Immunology, University of Texas Medical Branch

Timothy Cooke, Senior Vice President,, NVPO

Alan Cowman, Laboratory Head; Deputy Director, Science Strategy, Infectious Diseases and Immune Defence Division, The Walter & Eliza Hall Institute

Dr Rajeev Dadoo, Partner, S.R. One

Adil Daud, Professor Of Hematology, Oncology And Director, U.C.S.F. Helen Diller Family Comprehensive Cancer Center

Patrick Daugherty, Chief Scientific Officer And Founder, SerImmune

Tom Davis, Chief Medical Officer, Genocea Biosciences

Victor Defilippis, Associate Professor, Oregon Health and Science

Jason Devoss, Principal Scientist, Amgen

Daryl Drummond, Biotechnology Consultant

Erin Duffy, Chief Of Research And Development, CARB-X

Dr Roland Dunbrack, Professor, Fox Chase Cancer Center

Hugues Fontenelle, Bioinformatics Development Manager, NEC OncoImmunity AS

Leonard Friedland, Vice President, Scientific Affairs And Public Health Vaccines, North America, GSK

Dr Jeffrey Froude, Major, Stm, Vaccines And Therapeutics Division, Defense Threat Reduction Agency

Dr Evanthia Galanis, Professor, Chair Molecular Medicine, Mayo Clinic

Pamela Garzone, Chief Medical Officer, Calibr, a division of Scripps Research

Dr Hanspeter Gerber, Senior Vice President And Chief Scientific Officer, 3T Biosciences

Aubree Gordon, Associate Professor Of Epidemiology, University of Michigan School of Public Health

Farshad Guirakhoo, Chief Scientific Officer, GeoVax, Inc.

Ali M Harandi, Lab Head, Dpt Of Microbiology and Immunology, University of Gothenburg

Christian Harding, Chief Executive Officer, VaxNewMo

Wouter Hazenbos, Scientist, Genentech

William Heath, Scientific Advisor, Avalia Immunotherapies

Daniel Henderson, CEO, Verndari

Dr Robert Hollingsworth, Vice President And Chief Scientific Officer, Cancer Vaccines And Immunotherapeutics, Pfizer

Dr Peter Hotez, Dean, National School Of Tropical Medicine, Director, Texas Children?S Hospital Center, Baylor College of Medicine

Dr Huang Huang, Research Scientist,, Stanford University School of Medicine

Vanessa Hubbard-Lucey, Director, Cri Venture Fund And Clinical Accelerator, Cancer Research Institute

Hasan Jafri, Senior Director, Clinical Research And Development, Infectious Disease And Vaccines, MedImmune Inc

Risat Jannat, Director, Global Vaccines and Biologics Commercialization,, Merck

Risat Jannat | Director, Global Vaccines and Biologics Commercialization, | Merck » speaking at Vaccine West Coast

Jose Jimeno, CEO, Vaxtrials

Jose Jimeno | CEO | Vaxtrials » speaking at Vaccine West Coast

Hong Jin, Sr. Director/Fellow, Astra Zeneca

Vanessa Jonsson, Assistant Research Professor, City Of Hope

Dr Pravin Kaumaya, Director, Ohio State University

Lakshmi Khandke, Senior Program Advisor, PATH

Purvesh Khatri, Associate Professor, Stanford University School of Medicine

Douglas E Kiehl, Research Advisor, Bioproduct, Research & Development,, Eli Lilly and Company

Kevin Killeen, Chief Scientific Officer, Matrivax

Lacey Kitch, Director, Informatics, Parker Institute for Cancer Immunotherapy

Chester Kitchen, Cancer Patient Advocate

Steven Kleiboeker, Vice-President, Research And Development, Viracor Eurofins

Dr Vadim Klyushnichenko, Vice President Of Pharmaceutical Development And Quality, Calibr, a division of Scripps Research

Alexander Koglin, Founder, NTx

Dr Alexander Kort, Senior Vice President Corporate Development, Themis Bioscience

Christopher Larson, Vice President Vector Development, EpicentRx

Theresa Lavallee, Head Of Translational Medicine, Parker Institute for Cancer Immunotherapy

Samuel Lee, Life Sciences Principal, CincyTech

Dr Andrew Lees, Scientific Director, Fina BioSolutions

Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital Harvard Medical School

Anders Lilja, Vice President Technical Development, Hookipa Biotech

Jimmy Lin, Chief Scientific Officer, Freenome

Cheng Liu, Founder And Chief Executive Officer, Eureka Therapeutics

Cheng Liu | Founder And Chief Executive Officer | Eureka Therapeutics » speaking at Vaccine West Coast

Holden T Maecker, Director Immune Monitoring Core, Stanford University

David Maki, General Partner, Altitude Life Science Ventures

David Maki | General Partner | Altitude Life Science Ventures » speaking at Vaccine West Coast

Tyler Martin, Chief Executive Officer, Adjuvance Technologies

James McCarty, Clinical Professor of Paediatrics, Stanford University School of Medicine

Wouter Meuleman, Director, Venture Investments, Illumina Ventures

Francesca Milletti, Associate Director Translational Medicine,, Kite Pharma, a Gilead Company

Michael Mitchell, Professor, University of Pennsylvania

Rachel Mitrovich, Director, Global Vaccines Public Policy, Merck

Lenny Moise, Director Of Vaccine Research, EpiVax Inc

Lenny Moise | Director Of Vaccine Research | EpiVax Inc » speaking at Vaccine West Coast

Dr Martin Moore, Chief Executive Officer, Meissa Vaccines, Inc

Justin Moran, Senior Bioprocess Development Director, Pfizer

Umesh Muchhal, Director, Protein Engineering, Xencor, Inc.

Pralay Mukhopadhyay, Strategy Lead, Executive Director, Biometrics And Information Sciences, AstraZeneca

Pamela Munster, Professor, University of California San Francisco

Pamela Munster | Professor | University of California San Francisco » speaking at Vaccine West Coast

Michael Murray, Analyst, Biotechnology Value Fund

Duncan Mwangi, Research Director, Zoetis

Stephen Nagler, Executive Director, MedPro Investors Llc

Dr Susan Old, Deputy Director Of The Division Of Extramural Activities, NIAID

Dr Susan Old | Deputy Director Of The Division Of Extramural Activities | NIAID » speaking at Vaccine West Coast

Aaron Palmer Esser Kahn, Assistant Professor, Department of Chemistry University of California

Christa Pawlowski, Chief Operating Officer, SapVax LLC

Sari Pesonen, Head of R&D, Co-Founder, Valo Therapeutics

Elizabeth Pham, Scientist, Oncology, Amgen Inc

Tim Phares, Head Of Immunology, Explorations In Global Health (Exgloh), Leidos

Clemencia Pinilla, Associate Member, Torrey Pines Institute for Molecular Studies

Mary Jo Potter, Founder And Chief Executive Officer, Healthcare Angels

Krishna Prasad, Founder, Citranvi LLC

Brian Price, Chief Operating Officer, Blue Water Vaccines, Inc

Michael Princiotta, Vice President Of Research, EpiVax Oncology

Bali Pulendran, Department Of Pathology, Microbiology and Immunology, Stanford University School of Medicine

Jessicca Rege, Chief Development Officer, Oncologie

Tony Reid, Chief Scientific Officer, EpicentRx

John Ross, Vice President, Protein Therapeutics, Cue Biopharma

Gillie Roth, Bioengineering, Department of Materials Science & Engineering,, Stanford University

Dr Raphael Rousseau, Executive Vice President And Head Of Product Development And Chief Medical Officer, Gritstone Oncology

Sarah Royalty Tredo, Director, Emergent Biosolutions

Helen Sabzevari, President, Precigen

Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines

Bita Sahaf, Technical Director, Stanford Ccsu; Correlatives For Parker Institute For Cancer Immunotherapy; Snr Research Scientist, Stanford Cancer Institute

Juan Salazar, Executive Vice President, Connecticut Children's Medical Center

Richard Scheuermann, Director, J Craig Venter Institute

Dr Stephen Schoenberger, Professor, La Jolla Institute for Allergy and Immunology

Dr Mike Schopperle, Chief Executive Officer, CureMeta Llc

Martina Sersch, Chief Medical Officer, Independent

Dr Alessandro Sette, Center Head, Division Head, And Professor,, La Jolla Infectious Disease Institute

Vivek Shinde, Vice President, Clinical Development Lead, Older Adult Influenza And Rsv Vaccines, Novavax

Sujan Shresta, Associate Professor, La Jolla Institute for Immunology

Narinder Singh, Senior Vice President Of Pharmaceutical Sciences And Manufacturing, Genocea Biosciences

Kyle Smith, Director, Research And Development, MicroMedicine

William Smith, Chief Executive Officer, Alliance for Multispecialty Research LLC

Trevor Smith, Director Of Discovery, Preclinical, Research And Development, Inovio Pharmaceuticals

Dr Gary Starling, Associate Vice President, Discovery Biologics, Merck

Angelos Stergiou, President and Chief Executive Officer, Sellas Life Sciences

Dr Lesley Stolz, Managing Director, Lasana Partners

Nancy Sullivan, Chief, Biodefense Research Section, National Institutes of Health

Kena Swanson, Director, Pfizer

Kimberly Taylor, Project Officer And Biodefense Vaccines, National Institutes of Health

Dr Raymond Tesi, Chief Executive Officer, Inmunebio

Meghna Das Thakur, Biomarker Lead, T Cell Bi-Specifics, Genentech

Craig Thompson, Chief Scientific Officer, Blue Water Vaccines, Inc

Michael Tippie, General Manager, Alignment Ventures

Michael Tippie | General Manager | Alignment Ventures » speaking at Vaccine West Coast

Dr Sangeeta Tiwari, Associate (Faculty), Albert Einstein College of Medicine

Dr Steven Townson, Senior Principal Scientist, Early Oncology Development, Merck Research Laboratories

Ovid Trifan, Chief Medical Officer, Senior Vice President Of Clinical Development, Apexigen, Inc

Guy Tropper, Vice President of Medical Affairs and Co-Founder, Angany

Vu Truong, Chief Executive Officer And Chief Scientific Officer, Aridis Pharmaceuticals

Chia-Wei Tsai, Senior Scientist In Force Health Protection, USAMMDA

Dr Sean Tucker, Chief Scientific Officer And Vice President Research, Vaxart

Derek Ung, Principal Process Engineer, C.R.B.

Dr I Ming Wang, Director, Pfizer

Wen Bo Wang, Senior Vice President Of Technical Operations, Fate Therapeutics

Jo Anne Welsch, Scientific Director, Path

Jo Anne Welsch | Scientific Director | Path » speaking at Vaccine West Coast

David Whitacre, Senior Vice President, VLP Biotech

Prof Ignasio Wistuba, Professor And Chairman, The University of Texas MD Anderson Cancer Center

Kristen Wong, Associate, Altitude Life Science Ventures

Kristen Wong | Associate | Altitude Life Science Ventures » speaking at Vaccine West Coast

Lauren V Wood Md, Chief Medical Officer, P.D.S. Biotechnology Corp

Jenny Yip, Managing Partner, Adjuvant Capital

Jenny Yip | Managing Partner | Adjuvant Capital » speaking at Vaccine West Coast

Larry Zeitlin, President, Mapp Biopharmaceutical, Inc.

Heidi Zhang, Global Head Analytical Development Cell Therapy, Juno Therapeutics GmbH, A Celgene Company (BMS)

Hongbing Zhang, Senior Research Director, Eureka Therapeutics

Xiaoping Zhu, Associate Dean and Chair, University of Maryland College Park




Contact us

To sponsor or exhibit contact:
Oliver Breed
+44 (0)207 092 1156


To speak:
Lauren Sheppard
+44 (0)207 092 1211